Taysha (TSHA): Bathi sing dikarepake

TSHA (Taysha Gene Therapies Inc) - tandha merek perusahaan

The net income forecast for Taysha Gene Therapies (TSHA) reflects the current market valuation, where captures the magnitude of this parameter. Positive momentum is driven by the financial stability of Taysha Gene Therapies (TSHA) and the prospects for accelerated drug registration. The development vector is defined by the creation of unique viral gene delivery methods to the brain. A strong patent shield in Rett syndrome therapy provides a long-term advantage over competitors.

TSHA: Penghasilan resik sing dikarepake Taysha Corp 04.07.2022 - 19.11.2026

Taysha - rincian analitis lan metrik utama (TSHA)

Analisis kabeh metrik perusahaan:Taysha Corp, TSHA
Produk merek Taysha Gene Therapies Inc

Projected profit represents the discounted value of expected cash flows, allowing for an assessment of an asset's fair value through the lens of future earnings. By analyzing the profit trajectory of the enterprise, an investor can gauge the balance between the risk of overpayment and capital stability, which for Taysha Gene Therapies (TSHA) depends directly on the effectiveness of researchers in treating rare pathologies and the volume of laboratory funding.

Pesaing Taysha Gene Therapies

Bathi sing dikarepake Tempus AI|Proyeksi bathi mangsa ngarep Qiagen|Proyeksi bathi mangsa ngarep IONS|Bathi sing dikarepake RGEN (Repligen Corp.)|Avidity - Bathi mangsa ngarep|CRSP (crisprtx.com) - Bathi forward|WGS: Bathi mangsa ngarep|Proyeksi bathi resik Ultragenyx (RARE)|BEAM: Proyeksi bathi mangsa ngarep|Sarepta Therapeutics, Inc. (SRPT) - Proyeksi bathi mangsa ngarep|TWST (twistbioscience.com) - Proyeksi bathi mangsa ngarep|10x Genomics, Inc. (TXG) - Prakiraan bathi perusahaan|Bathi mangsa ngarep NTLA (Intellia Therapeutics, Inc.)|STOK - Bathi resik sing dikarepake|Bathi sing dikarepake biolifesolutions.com BLFS|Prakiraan bathi perusahaan Wave Life Sciences Corp (WVE)|MAZE - Bathi sing dikarepake|Penghasilan resik sing dikarepake SION (Sionna Therapeutics Inc)|PRME: Proyeksi bathi mangsa ngarep|QURE - Prakiraan bathi perusahaan|MGTX (MeiraGTx Holdings plc) - Proyeksi bathi mangsa ngarep|Bathi mangsa ngarep REGENXBIO Inc. (RGNX)|Bathi sing dikarepake Solid Biosciences (SLDB)|ocugen.com (OCGN) - Proyeksi bathi resik|Proyeksi bathi mangsa ngarep PACB (PacBio Corp)|Penghasilan resik sing dikarepake BNTC|DSGN: Bathi mangsa ngarep|RCKT - Proyeksi bathi mangsa ngarep|Penghasilan resik sing dikarepake 4D Molecular Corp FDMT|Bathi mangsa ngarep Lexeo|Bathi sing dikarepake Korro Bio Inc.|Prakiraan bathi resik EDIT (Editas Medicine)|Bathi sing dikarepake Silence Therapeutics Corp (SLN)|PRQR (ProQR) - Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep CDXS (Codexis, Inc.)|Prakiraan bathi perusahaan sangamo.com (SGMO)|nautilus.bio - Proyeksi bathi mangsa ngarep|Metagenomi (MGX) - Bathi mangsa ngarep|DTIL: Proyeksi bathi mangsa ngarep|Bathi resik sing dikarepake Generation Bio Co (GBIO)|BOLD (Boundless Bio) - Proyeksi bathi mangsa ngarep|Bathi mangsa ngarep Exicure (XCUR)|Bathi sing dikarepake Celsion Corporation (IMNN)|PHIO - Bathi resik sing dikarepake|Mustang Bio Inc - Bathi mangsa ngarep|Proyeksi bathi mangsa ngarep transcodetherapeutics.com RNAZ|Bionano Genomics Inc. - Proyeksi bathi mangsa ngarep|APDN (Applied DNA Sciences) - Prakiraan bathi resik|BLUE (bluebirdbio.com) - Bathi mangsa ngarep|Prakiraan bathi resik IPA|OMGA (omegatherapeutics.com) - Proyeksi bathi mangsa ngarep|Singular Genomics Systems Inc (OMIC) - Prakiraan bathi perusahaan|Proyeksi bathi mangsa ngarep RGLS|Prakiraan bathi perusahaan Syros Pharmaceuticals, Inc.|Bathi sing dikarepake Telesis Bio Inc. TBIO|Bathi resik mangsa ngarep TCON (TRACON Pharmaceuticals Inc.)|Unity Bio - Proyeksi bathi mangsa ngarep